Theravance Biopharma, Inc. (TBPH) Operating income 2016–2025
Theravance Biopharma, Inc. (TBPH) annual operating income history from SEC filings — each fiscal year as reported.
-$3.6MFY2025 · since FY2016: -$180.5M → -$3.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$3.6M | +92.3% |
| FY2024 | -$46.9M | +16.2% |
| FY2023 | -$56.0M | +39.1% |
| FY2022 | -$92.0M | +64.3% |
| FY2021 | -$257.8M | +13.4% |
| FY2020 | -$297.6M | -18.1% |
| FY2019 | -$251.9M | -5.5% |
| FY2018 | -$238.8M | +8.2% |
| FY2017 | -$260.1M | -44.1% |
| FY2016 | -$180.5M | — |
Source: SEC XBRL filings · For reference only · Not investment advice